Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Premature Termination of a Randomized Controlled Trial on Image-Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    Research output: Contribution to journalReviewResearchpeer-review

  3. Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of a new sagittal classification system in adolescent idiopathic scoliosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of Service User Involvement from the Perspective of Adolescents and Young Adults with Cancer Experience

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

LESSONS LEARNED: It is possible to plan and treat some patients with stereotactic body radiotherapy (SBRT) in a timely fashion in an acute setting.Advanced and, in some indications, already implemented technologies such as SBRT are difficult to test in a randomized trial.

BACKGROUND: Stereotactic body radiotherapy (SBRT) in metastatic spinal cord compression (MSCC) could be an alternative to decompressive surgery followed by fractionated radiotherapy.

METHODS: In a randomized, single-institution, noninferiority trial, patients with MSCC were assigned to stereotactic body radiotherapy of 16 Gy in 1 fraction or decompression surgery followed by fractionated radiotherapy of 30 Gy in 10 fractions. Primary endpoint was ability to walk by EQ5D-5L questionnaire. Based on power calculations, 130 patients had to be included to be 89% sure that a 15% difference between the treatment arm and the experimental arm could be detected.

RESULTS: Ten patients were accrued in 23 months, with six patients allocated to surgery and four patients to stereotactic body radiotherapy. The trial was closed prematurely because of poor accrual. One patient undergoing surgery and one patient undergoing stereotactic body radiotherapy were unable to walk at 6 weeks. Two patients were not evaluable at 6 weeks.

CONCLUSION: A randomized, phase II, clinical trial comparing surgery followed by fractionated radiotherapy or image-guided SBRT of MSCC was initiated. SBRT was shown to be feasible, with three out of four patients retaining walking function. The trial was determined futile as a result of low accrual.

Original languageEnglish
JournalThe oncologist
Volume25
Issue number3
Pages (from-to)210-e422
ISSN1083-7159
DOIs
Publication statusPublished - 1 Mar 2020

ID: 58596588